Core Viewpoint - Avalon GloboCare Corp. has acquired RPM Interactive, Inc., a generative AI publishing and software company, and is focusing on the development and commercialization of the Catch-Up platform, a SaaS solution for automated video generation [1][2]. Group 1: Acquisition and Leadership - Michael Mathews, CEO of RPM and a board member of Avalon, discussed the acquisition and its implications during an interview [1]. - The acquisition of RPM is part of Avalon's strategy to enhance its product offerings in the precision diagnostic consumer products sector [1]. Group 2: Catch-Up Platform Development - The Catch-Up platform is designed to automatically generate recap-style videos using generative AI applications and large language models [2]. - This platform will be marketed to content creators, media companies, and brands, allowing them to produce videos without manual editing or technical expertise [3]. Group 3: Marketing and Product Integration - Avalon plans to utilize the Catch-Up platform to support marketing initiatives for its KetoAir™ breathalyzer, which is FDA-registered and aimed at helping consumers manage their wellness [4]. - The integration of the Catch-Up platform is expected to enhance the volume of video content produced by content creators, thereby increasing engagement and visibility [3].

FREEHOLD, N.J., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced that Michael Mathews, a member of the Company’s Board of Directors and Chief Executive Officer of RPM Interactive, Inc. (“RPM”), participated in an interview with Proactiveinvestors.com. Recently, the Company announced that it has acquired RPM Interactive, Inc. (“RPM”), a generative artificial intelligence (“AI”) publishin ...

Core Viewpoint - Avalon GloboCare Corp. is launching the KetoAir™ breathalyzer device in the UK, expanding its market presence following its U.S. launch, targeting individuals on ketogenic diets for health management [1][3]. Product Overview - KetoAir™ is a handheld breathalyzer that measures breath acetone concentration (BrAce), indicating fat metabolism and ketosis, and is registered as a Class I medical device with the U.S. FDA [2][4]. - The device is designed for users pursuing ketogenic diets for weight loss, athletic performance, or therapeutic purposes, utilizing advanced nano-sensor technology for real-time metabolic insights [2][3]. Market Strategy - The launch in the UK is seen as a strategic move to capitalize on the growing adoption of ketogenic and low-carb diets, positioning KetoAir™ as a tool to help individuals achieve their health and wellness goals [3]. - The product will be available for purchase starting September 1, 2025, through the dedicated website [1][3]. Company Background - Avalon GloboCare Corp. focuses on developing precision diagnostic consumer products and advancing intellectual property in cellular therapy, with plans to explore additional diagnostic uses for the breathalyzer technology [4].

Core Insights - Avalon GloboCare Corp. has partnered with SpecialtyHealth, Inc. to enhance its BrAce 4 Impact Challenge, integrating SpecialtyHealth into its Zero to Keto Affiliate Marketing Program [1][6] - The KetoAir™ breathalyzer is being utilized by law enforcement as a motivational tool to support health and wellness initiatives [2][3] - The collaboration aims to promote healthier habits among first responders by managing ketone levels through the use of the KetoAir™ device [4][6] Company Overview - Avalon GloboCare Corp. is focused on developing precision diagnostic consumer products and advancing intellectual property in cellular therapy [8] - The company is currently marketing the KetoAir™ breathalyzer, which is registered as a Class I medical device with the U.S. Food and Drug Administration [6][8] - Avalon also operates in the commercial real estate sector, indicating a diversified business model [8] Product Details - The KetoAir™ breathalyzer measures breath acetone concentration, providing real-time insights into an individual's ketosis status [6] - The device is designed for ease of use, fitting into a uniform pocket for convenient monitoring by law enforcement officers [3] - The technology behind KetoAir™ leverages nano-sensor capabilities to assess ketone levels, supporting users in their weight management efforts [6]

Core Insights - Avalon GloboCare Corp. has partnered with Pounds Transformation Clinics to launch the "BrAce 4 Impact Challenge Series," utilizing the KetoAir™ breathalyzer as a motivational tool for weight management [1][5] - The inaugural challenge began on April 1, 2025, following a successful pilot program that concluded on March 18, 2025, demonstrating positive results for participants [2][5] - The KetoAir™ device measures breath acetone concentration, providing real-time feedback on ketosis status, which aids users in their weight loss journey [4][5] Company Overview - Avalon GloboCare Corp. is a commercial-stage company focused on developing precision diagnostic consumer products, including the KetoAir™ breathalyzer [6] - The company aims to expand its diagnostic applications of breathalyzer technology and also operates in the commercial real estate sector [6] Partnership Details - The partnership with Pounds Transformation Clinics is designed to enhance patient engagement and support through dedicated coaching and real-time tracking of ketone levels [2][5] - Dr. Charles Cavo, a key figure in the partnership, reported significant weight loss results among participants using the KetoAir™ device, indicating its effectiveness in promoting accountability and motivation [2][5] Product Information - The KetoAir™ breathalyzer is FDA registered and utilizes nano-sensor technology to assess ketosis, available for download on both Apple and Google platforms [4] - The device has been integrated into Pounds Transformation's programs, allowing patients to monitor their health and progress effectively [5]